.png){kind=icon}
.png){kind=icon}
Return
Modernizing cognitive assessment in Alzheimer’s disease
.png){kind=icon}
PRE
AI
C
C
DOI：10.1038/s43587-026-01185-0.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Blood biomarkers enable early detection of Alzheimer’s disease pathology, but clinical pathways wait to detect late-stage cognitive impairment. Digital cognitive assessments that target Alzheimer’s-disease-vulnerable systems can detect earlier functional change and strengthen plasma-biomarker prognosis. Modernizing cognition is essential for true early detection in Alzheimer’s disease.
Journal
IF:
19.4
Papers:
1.2K
Citations:
6.4K
Organization
Cited Papers